期刊文献+

糖尿病肾病患者的降压治疗 被引量:2

Antihypertensive Therapy for the Patients with Diabetic Nephropathy
下载PDF
导出
摘要 高血压是糖尿病的常见合并症,也是糖尿病肾病的常见表现。糖尿病与高血压并存对心、脑、肾的损害程度远远大于单纯性高血压或单纯性糖尿病。英国前瞻性糖尿病研究(UKPDS)首次提出严格控制血压与严格控制血糖对于延缓糖尿病并发症的发展同样重要。因此,对于糖尿病肾病合并高血压的早期诊断和进行有效的降压治疗,值得关注。 Hypertension is a common complication of diabetes,and also the common manifestation of diabetic nephropathy.The damage of coexisting diabetes and hypertension to heart,brain,and kidney is greater than the damage by hypertension or diabetes alone.United Kingdom Prospective Diabetes Study(UKPDS was the first to introduce that,strict control of hypertension was as important as strict control of blood sugar level in the slowing the progress of the complications of diabetes.Therefore,attention should be paid to the early diagnosis and effective treatment for diabetic nephropathy in combination with hypertension.
作者 陈鲁原
出处 《中国处方药》 2010年第7期46-48,共3页 Journal of China Prescription Drug
  • 相关文献

同被引文献31

  • 1Ambroisine ML, Milliez P, Nehme J, et al. Aldosterone and anti-al- dosterone effects in cardiovascular diseases and diabetic nephropa- thy[J]. Diabetes Metab,2004,30(4) :311-318.
  • 2Brown NJ. Aldosterone and vascular inflammation [ J ]. Hyperten- sion ,2008,51 ( 2 ) : 161-167.
  • 3Luther JM, Gainer JV, Murphey LJ. Angiotensin Ⅱ induces inter- leukin-6 in humans through a mineralocorticoid receptor-dependent mechanism[ J]. Hypertension ,2006,48 ( 6 ) : 1050-1057.
  • 4Ferrari P. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease [ J ]. Neph- rology,2007,12( 1 ) :81-89.
  • 5Gasparo MDE, Levens NR. Pharmacology of angiotensin II receptor in the kidney [ J ]. Kidney Int, 1994,46 (6) : 1486-1491.
  • 6Remuzzi A, Perticucci E, Reggenenti P, et al. Angiotensin conver- ting enzyme inhibition improve glomarular size selecti-vity in IgA nephropathy [ J ]. Kidney Int, 1991,39 ( 6 ) : 1267-1273.
  • 7Woo KT, Lau YK, Wong KS, et al. ACE][/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephri- tis[ J]. Kidney Int,2000,58 ( 6 ) :2485-2491.
  • 8Nakao N,Yoshimura A, Morita H, et al. Combination treatment of angiotensin- II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease( COOPER ATE) :a random- ised controlled trial[ J ]. Lancet,2003,361 (9352) : 117-124.
  • 9Krum H,Carson P, Farsang C, et al. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure:re- sults from Val-HeFT[ J]. Eur J HeartFail,2004,6(7) :937.
  • 10McMurray J J, Ostergren J, Swedberg K,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial [ J ]. Lancet,2003,362 (9386) : 767 -771.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部